multiple sclerosis

Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Roche
Novartis
Kesimpta
Ocrevus
MS
multiple sclerosis
TG adds a multiple sclerosis string to its bow
EP Vantage
Fri, 12/11/20 - 11:07 am
TG Therapeutics
hematology
ASH2020
ublituximab
MS
multiple sclerosis
MediciNova's Ibudilast Reduces Retinal Thinning in MS Trial Subjects
BioSpace
Wed, 11/25/20 - 10:38 am
MediciNova
OCT
clinical trials
ibudilast
MS
multiple sclerosis
retinal thinning
GW Pharma Hopes to Bring Its Second Cannabis-Based Drug to Market in the U.S.
BioSpace
Tue, 11/3/20 - 09:34 pm
GW Pharma
cannabindoids
multiple sclerosis
spasticity
nabiximols
Sativex
Anokion announces FDA clearance of IND application for ANK-700 to treat multiple sclerosis
Pharmaceutical Business Review
Fri, 09/25/20 - 10:40 am
Anokion
ANK-700
multiple sclerosis
Novartis set to take on Roche as FDA clears first at-home, injectable MS drug
Biopharma Dive
Thu, 08/20/20 - 10:52 pm
Novartis
FDA
Kesimpta
ofatumumab
MS
multiple sclerosis
Teva shares slide as it faces illegal kickback charges from US government
Pharmaforum
Thu, 08/20/20 - 10:59 am
Teva Pharmaceutical
kickbacks
DOJ
Copaxone
MS
multiple sclerosis
Mylan launches first generic to Tecfidera in multiple sclerosis
Seeking Alpha
Wed, 08/19/20 - 09:26 am
Mylan
generics
Tecfidera
Biogen
MS
multiple sclerosis
U.S. court upholds patent for Novartis MS drug Gilenya
Reuters
Tue, 08/18/20 - 11:04 am
Novartis
patents
Gilenya
MS
multiple sclerosis
Sanofi, seeking control of key drug, to buy Principia for $3.7B
BioPharma Dive
Mon, 08/17/20 - 01:03 pm
Sanofi
Principia Biopharma
M&A
multiple sclerosis
MS
SAR442168
Immunic's lead MS drug hits primary and key secondary endpoints in PhII, but questions remain
Endpoints
Mon, 08/3/20 - 10:22 am
Immunic
MS
multiple sclerosis
clinical trials
IMU-838
Biogen points to COVID-19 for disappointing drug launch
BioPharma Dive
Wed, 07/22/20 - 11:42 pm
Biogen
Vumerity
MS
multiple sclerosis
Roche, PicnicHealth start RWD partnership with multiple sclerosis focus
MedCity News
Mon, 07/20/20 - 10:32 am
Roche
PicnicHealth
MS
multiple sclerosis
RWD
real world data
artificial intelligence
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
Xconomy
Mon, 07/6/20 - 10:48 am
Bristol-Meyers Squibb
Dragonfly Therapeutics
multiple sclerosis
MS
neuroinflammation
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Mon, 06/22/20 - 08:36 pm
Biogen
Tecfidera
Mylan
patents
generics
MS
multiple sclerosis
Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan
Fierce Pharma
Thu, 06/18/20 - 10:44 am
Biogen
Mylan
Tecfidera
patents
MS
multiple sclerosis
Bristol Myers Squibb's Zeposia launches into crowded MS market
Fierce Pharma
Tue, 06/2/20 - 10:50 am
Bristol-Myers Squibb
Celgene
Zeposia
drug launches
MS
multiple sclerosis
Novartis builds case for MS drug ofatumumab as FDA decision looms
Pharmaforum
Wed, 05/27/20 - 10:22 am
Novartis
ofatumumab
clinical trials
MS
multiple sclerosis
Sanofi posts data from contentious phase 2 multiple sclerosis trial
Fierce Biotech
Thu, 04/23/20 - 09:15 pm
Sanofi
clinical trials
MS
multiple sclerosis
Principia Biopharma
SAR442168
Early treatment with Novartis' Mayzent stalls secondary progressive MS: study
Fierce Pharma
Tue, 04/21/20 - 11:55 pm
Novartis
Mayzent
MS
multiple sclerosis
Gilenya

Pages